About

Dario Ribero is a leading colorectal surgeon whose work is redefining the standards of minimally invasive oncologic surgery. His primary research focuses on optimizing surgical techniques for colon and rectal cancer, specifically through robotic and laparoscopic approaches. Ribero is a pioneer in the application of Complete Mesocolic Excision (CME) and D3 lymphadenectomy, demonstrating in a landmark study of 202 patients (cited 131 times) that robotic right colectomy can achieve superior perioperative outcomes and 5-year survival rates compared to laparoscopic methods. He has been instrumental in advancing fluorescence-guided surgery, notably through the GREENLIGHT trial, using Indocyanine Green (ICG) to visualize lymphatic drainage in real-time, ensuring more complete lymph node removal. His innovative "suprapubic approach" and "double ICG technique" for robotic right colectomy have been widely adopted, improving both oncologic safety and anastomotic integrity. With a portfolio of highly cited papers and a focus on single-port (da Vinci SP) surgery, Ribero’s work is shaping the future of precision, minimally invasive colorectal cancer care.

Research Focus

Key Achievements

7
H-Index
11
Papers
269
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients
131 citations · 2018
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 97
🏛 Institutions: Candiolo Cancer Institute, Ripamonti, MultiMedica, European Institute of Oncology, Istituti di Ricovero e Cura a Carattere Scientifico, Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago